Thrive’s CancerSEEK uses blood tests for early multi-cancer detection
Endpoints News - 28-Apr-2020Demonstrated in a large prospective study involving patients without cancer history
Join the club for FREE to access the whole archive and other member benefits.
Blood test, Thrive Early Detection
CancerSEEK is a blood test (also called a liquid biopsy) designed to detect multiple types of cancer at the earliest stages possible, before noticeable symptoms occur.
CancerSEEK is being developed to combine cutting-edge liquid biopsy technology with a machine learning engine, which will enable the test to improve with every person that is screened. It is designed to be integrated into your routine medical care, alongside other existing cancer screening tools.
Visit website: https://thrivedetect.com/cancerseek.html
See also: Thrive Earlier Detection Corp. - Biotechnology company, Massachusetts
Details last updated 02-May-2020
Demonstrated in a large prospective study involving patients without cancer history